Moderna Rises After Vaccine Data Support Larger Study

(Bloomberg) -- Moderna Inc. is broadening its testing of a vaccine for a leading infectious cause of birth defects after early-stage clinical results showed it induced immune responses in patients.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.